Molecular Cancer Impact Factor, Indexing, Ranking

Molecular Cancer Impact Factor, Indexing, Ranking

Molecular Cancer (MC) is a scholarly journal dedicated to publishing research in the field of Medicine. BioMed Central is the publisher of this esteemed journal. and its abbreviated form is Mol Cancer.


Molecular Cancer Aim and Scope

Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.


Molecular Cancer Details


Journal title Molecular Cancer (MC)
Abbreviation Mol Cancer
Online ISSN 1476-4598
Publisher Name BioMed Central
Editor-in-chief Cristophe Nicot
Subject Category Medicine

Molecular Cancer Abbreviation

Molecular Cancer Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Molecular Cancer Journal is Mol Cancer.


Molecular Cancer Ranking

The Ranking of Molecular Cancer in 2026 is 96. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.


Molecular Cancer Impact Factor

The Impact Factor of Molecular Cancer in 2026 is 33.1. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors


Molecular Cancer SCImago

The SCImago of Molecular Cancer in 2026 is 8.703. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.


Molecular Cancer H-Index

The H-Index of Molecular Cancer in 2026 is 171. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.


Molecular Cancer Quartile

The Quartile of Molecular Cancer is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.


Molecular Cancer Indexing

The Molecular Cancer is indexed in (Indexing details)

PubMed Scopus Web of Science UGC Embase DOAJ

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.


Molecular Cancer Metrics for 2026


Abbreviation Mol Cancer
Access type Hybrid
Impact Factor 33.1
SJR 8.703
SNIP 5.740
Ranking 96
CiteScore 64.9
H-Index 171

Molecular Cancer Editorial Board

The Editor-in-chief of Molecular Cancer is Cristophe Nicot


Molecular Cancer Submission/Processing Fee (APC)

Molecular Cancer Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of Molecular Cancer is 4890.00 USD


Molecular Cancer Call for paper

Molecular Cancer Call for paper : Molecular Cancer invites original research contributions for consideration of publication in Molecular Cancer journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.


How to publish in Molecular Cancer

Publishing in Molecular Cancer involves the following steps:

  • Research: Conduct high-quality, impactful research in the field of Medicine.
  • Familiarize Yourself: Read and understand the aims and scope of Molecular Cancer to ensure your work aligns with their focus.
  • Manuscript Preparation: Prepare your manuscript according to the Molecular Cancer guidelines, including formatting, length, and referencing style.
  • Submission: Submit your manuscript through the journal's online submission system.

Molecular Cancer FAQ

is Molecular Cancer journal indexed in PubMed?

Yes, the Molecular Cancer journal is indexed in PubMed.

is Molecular Cancer journal indexed in Scopus?

Yes, the Molecular Cancer journal is indexed in Scopus.

is Molecular Cancer journal indexed in UGC?

Yes, the Molecular Cancer journal is indexed in UGC.

is Molecular Cancer journal indexed in Index Copernicus?

No, the Molecular Cancer journal is not indexed in Index copernicus.

is Molecular Cancer a predatory journal?

No, Molecular Cancer journal is not a predatory journal.

What is the Imptact Factor of Molecular Cancer?

The Impact Factor of the Molecular Cancer is 33.1.

What is the Ranking of Molecular Cancer?

The Ranking of the Molecular Cancer is 96.

is Molecular Cancer peer reviewed journal?

Yes the Molecular Cancer (MC) journal is a peer-reviewed journal.

is Molecular Cancer a good journal?

Yes the Molecular Cancer journal is a peer-reviewed journal and good to publish your paper.

What is Molecular Cancer?

Molecular Cancer (MC) is a scholarly journal dedicated to publishing research in the field of Medicine. BioMed Central is the publisher of this esteemed journal.

is Molecular Cancer open access?

Yes, Molecular Cancer is a open access (Hybrid) journal.


Impact factor List